You can purchase shares of Catalyst Pharmaceuticals (NASDAQ:CPRX) through any online brokerage.

View our list of the best stock brokerages

Other companies in Catalyst Pharmaceuticals’s space includes: IDEAYA Biosciences Inc (NASDAQ:IDYA), Immunome Inc (NASDAQ:IMNM), Legend Biotech Corp (NASDAQ:LEGN), Twist Bioscience Corp (NASDAQ:TWST) and Arcutis Biotherapeutics Inc (NASDAQ:ARQT).

Catalyst Pharmaceuticals has a consensus price target of $33.00.

The stock price for Catalyst Pharmaceuticals (NASDAQ: CPRX) is $24.99 last updated April 1, 2026 at 4:33 AM EDT.

There are no upcoming dividends for Catalyst Pharmaceuticals.

Catalyst Pharmaceuticals does not have any upcoming earnings scheduled.

There is no upcoming split for Catalyst Pharmaceuticals.

Catalyst Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.